Conbercept (KH902)

conbercept · Chengdu Kanghong Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Conbercept (KH902), covering 2017-02-16 to 2017-02-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word（STONE）

See pricing